Conclusions Increased Lp(a) in colorectal cancer patients can be associated with its anti-tumor effect. Alterations in the blood lipid profile raises a new issue concerning the safety of lipid-lowering therapy in colorectal cancer patients complicated by CHD.
结论结直肠癌患者Lp(a)水平的升高可能与其抗肿瘤效应有关,合并冠心病的直结肠癌患者血脂谱的变化为在此类患者中进行调脂治疗的安全性提出了新的课题。
参考来源 - 冠心病合并结直肠癌对血脂水平的影响及他汀类药物调脂的意义·2,447,543篇论文数据，部分数据来源于NoteExpress
The criteria by CDS could reflect the change in blood lipid profile in Chinese population more objectively.
在中国人群中，CDS诊断标准能更客观地反映这种血脂谱的变化。
Additionally, patients visited the clinic at one, three and six months following start of treatment. At each visit, BMI, blood pressure, lipid profile and total antioxidant status were recorded.
除此之外，病人在实验开始后的第一个月、第三个月和第六个月到医院复查。每次检查都会记录病人的BMI、血压、血脂水平、和整体抗氧化水平。
Levels of blood glucose, glycated serum protein, insulin and lipid profile were determined.
测定血糖、糖化血清蛋白、血脂和胰岛素水平。
应用推荐